Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…e and fludarabine, followed by a single intravenous infusion of rapcabtagene autoleucel, with the initial three dosed sequentially with a 28-day observ…
…ptosis was determined at baseline, and following treatment with cyclophosphamide, a PERK or a FOXO1-inhibitor using TUNEL and cleaved caspase 9/…
… mean disease duration was 7.2±6.2 years. All patients received prednisolone at mean dose of 10.6±4.3 mg/day. 9% of patients received cyclop…
…uently treated with corticosteroids (79.3% vs. 67.9%, p=0.003), cyclophosphamide (43.4% vs. 26%, p<0.001), and azathioprine (38.5% vs. 22.3%, p=…
… found a negative correlation level of IL-13 with total dose of cyclophosphamide (R=-0.248 (p<0.05)).Conclusions Our dates indirectly confirm th…
…nts recieved corticosteroids, and 48.7% recieved antimalarials. Mycophenolate mofetil, rituximab and cyclophosphamide were the most commonly used imm…
…analyze long term outcome of patients with SSc-ILD treated with tocilizumab (TCZ), rituximab (RTX), and abatacept (ABA) which became availa…
…urgitation. Exposure to immunosuppressive agents (methotrexate, mycophenolate mofetil, azathioprine, cyclophosphamide, tacrolimus, leflunomide, ritux…
…SP was 21mmHg. HRCT Scan confirmed mild ILD.He was commenced on mycophenolate mofetil, amlodipine and omeprazole. Mid-2023 he presented with shortnes…
… fibrin, but no active infection or granuloma.Results Following Rituximab and subsequent initiation of mycophenolate mofetil (MMF), there…
… kinase (JAK) – STAT signalling in PSM pathogenesis, suggesting ruxolitinib, a JAK 1/2 inhibitor, as potential therapeutic option [N Engl J…
… study comparing autologous stem cell transplantation (HSCT) to cyclophosphamide (CYC) in diffuse cutaneous (dc)SSc. Serum concentrations of the…